Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Prilenia
3227
Prilenia
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
Prilenia Therapeutics is a clinical stage biotech startup founded in 2018 with the purpose of improving the lives of patients and their families by developing treatments for neurodegenerative and neurodevelopmental disorders.
Suggest edits
Founded
2018
Raised
$62.5M
Follow us
Also headquartered in Boston
General Electric
DraftKings
Bain Capital
Sophia
TA Associates
Wikibon
Zipcar
State Street
DataRobot
Battery Ventures
Companies in the same industry
Molcure
Ultragenyx Pharmaceutical
Perlecan Pharma
Thermosome
Polyneuron
Nuo Therapeutics
Rgenix
XOR Labs Toronto
Sirenas Marine Discovery
Atriva Therapeutics
Alexa global traffic share
Overview
Funding
1
Add info
Latest funding
$62,500,000
Venture capital (Series A) - 2020
Forbion Capital Partners
Sectoral Asset Management
Morningside Venture Investments
+1
Team Size
1–10
Employees
I work here
Location
Boston
,
United States
Headquarters
Explore Boston
$62,500,000
Venture capital (Series A)
FinSMEs
Prilenia Therapeutics Raises $62.5M in Series A Funding
